Author's reply to Phillips and Brugts

Affiliations

Comment

Colin R Dormuth. BMJ. 2014.

. 2014 Jul 30:349:g4890.

doi: 10.1136/bmj.g4890.

¹ Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Victoria, BC, Canada V8W 1Y2 colin.dormuth@ti.ubc.ca.

No abstract available

Comment on

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.
Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L; Canadian Network for Observational Drug Effect Studies Investigators. Dormuth CR, et al. BMJ. 2014 May 29;348:g3244. doi: 10.1136/bmj.g3244. BMJ. 2014. PMID: 24874977 Free PMC article.
Epidemiological data on higher potency statins and new diabetes should not deter clinicians from prescribing statins.
Phillips CA. Phillips CA. BMJ. 2014 Jul 30;349:g4874. doi: 10.1136/bmj.g4874. BMJ. 2014. PMID: 25078018 No abstract available.
Unanswered questions about higher potency statins and the risk of new diabetes.
Brugts JJ. Brugts JJ. BMJ. 2014 Jul 30;349:g4876. doi: 10.1136/bmj.g4876. BMJ. 2014. PMID: 25079055 No abstract available.